Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Where Research, Medicine and Care Converge: A CMO Roundtable Discussion

Session Chair(s)

Michael  Rosenblatt, MD

Michael Rosenblatt, MD

Chief Medical Officer

Flagship Pioneering, United States

Patients today confront challenges that reach far beyond the diagnosis itself, such as what information to believe, understanding that information, and how to apply it to achieve better health. Today’s chief medical officers reside squarely at the intersection of innovation, patient advocacy, safety and well being, and communication, and play a unique role in their respective organizations. This panel of chief medical officers will discuss their responsibilities to patients and in improving health care in an evolving landscape.

Learning Objective : Discuss unique facets of the role of a chief medical officer (CMO); Describe the responsibility a CMO has to patients and in improving health care.

Speaker(s)

Tim  Garnett, MD

Panelist

Tim Garnett, MD

Eli Lilly and Company, United States

Chief Medical Director and Senior Vice President

Richard L Schilsky, MD

Panelist

Richard L Schilsky, MD

American Society of Clinical Oncology, United States

Chief Medical Officer

Valentin  Fuster, MD, PhD

Panelist

Valentin Fuster, MD, PhD

Mount Sinai Medical Center, United States

Physician-in-Chief

Edmund Joseph Pezalla, MD, MPH

Panelist

Edmund Joseph Pezalla, MD, MPH

Enlightment Bioconsult, LLC, United States

Chief Executive Officer

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.